Macquarie Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-255,116
| Closed | -$14M | – | 1062 |
|
|
2025
Q3 | $14M | Sell |
255,116
-25,611
| -9% | -$1.28M | 0.02% | 747 |
|
|
2025
Q2 | $14.9M | Buy |
280,727
+21,068
| +8% | +$1.07M | 0.02% | 738 |
|
|
2025
Q1 | $11.2M | Sell |
259,659
-89,472
| -26% | -$4.53M | 0.01% | 785 |
|
|
2024
Q4 | $19.6M | Sell |
349,131
-1,193,741
| -77% | -$74.3M | 0.02% | 656 |
|
|
2024
Q3 | $105M | Buy |
1,542,872
+1,313
| +0.1% | +$74.1K | 0.11% | 247 |
|
|
2024
Q2 | $65.1M | Buy |
1,541,559
+1,059,812
| +220% | +$58.3M | 0.07% | 342 |
|
|
2024
Q1 | $33.3M | Buy |
481,747
+225,603
| +88% | +$14.3M | 0.04% | 557 |
|
|
2023
Q4 | $18.9M | Sell |
256,144
-42,419
| -14% | -$2.78M | 0.02% | 676 |
|
|
2023
Q3 | $20.4M | Sell |
298,563
-31,279
| -9% | -$2.65M | 0.03% | 636 |
|
|
2023
Q2 | $31M | Sell |
329,842
-32,857
| -9% | -$2.56M | 0.04% | 561 |
|
|
2023
Q1 | $24.6M | Buy |
362,699
+30,212
| +9% | +$1.94M | 0.03% | 614 |
|
|
2022
Q4 | $16.5M | Buy |
332,487
+68,277
| +26% | +$2.79M | 0.02% | 728 |
|
|
2022
Q3 | $8.58M | Sell |
264,210
-1,851,393
| -88% | -$76.3M | 0.01% | 865 |
|
|
2022
Q2 | $83.3M | Sell |
2,115,603
-869,235
| -29% | -$46.5M | 0.09% | 290 |
|
|
2022
Q1 | $209K | Buy |
2,984,838
+1,232,096
| +70% | +$90.1M | 0.16% | 121 |
|
|
2021
Q4 | $136M | Sell |
1,752,742
-528,508
| -23% | -$46.6M | 0.11% | 239 |
|
|
2021
Q3 | $218M | Sell |
2,281,250
-128,965
| -5% | -$13.6M | 0.19% | 123 |
|
|
2021
Q2 | $300M | Buy |
2,410,215
+168,144
| +7% | +$20.1M | 0.25% | 87 |
|
|
2021
Q1 | $295M | Buy |
2,242,071
+298,456
| +15% | +$40.9M | 0.42% | 47 |
|
|
2020
Q4 | $258M | Sell |
1,943,615
-222,138
| -10% | -$26.9M | 0.38% | 49 |
|
|
2020
Q3 | $221M | Buy |
2,165,753
+684,835
| +46% | +$59.1M | 0.37% | 46 |
|
|
2020
Q2 | $129M | Buy |
1,480,918
+458,464
| +45% | +$36.6M | 0.22% | 78 |
|
|
2020
Q1 | $59.3M | Buy |
1,022,454
+67,271
| +7% | +$5.46M | 0.12% | 162 |
|
|
2019
Q4 | $88.3M | Buy |
955,183
+479,812
| +101% | +$42.2M | 0.13% | 144 |
|
|
2019
Q3 | $43M | Buy |
475,371
+128,961
| +37% | +$14.7M | 0.07% | 287 |
|
|
2019
Q2 | $40.9M | Buy |
346,410
+228,639
| +194% | +$23M | 0.07% | 298 |
|
|
2019
Q1 | $10.2M | Sell |
117,771
-28,702
| -20% | -$2.44M | 0.02% | 617 |
|
|
2018
Q4 | $9.24M | Sell |
146,473
-182,168
| -55% | -$12.5M | 0.02% | 609 |
|
|
2018
Q3 | $25.9M | Sell |
328,641
-393,693
| -55% | -$25.7M | 0.04% | 413 |
|
|
2018
Q2 | $43.2M | Sell |
722,334
-240,259
| -25% | -$12.9M | 0.07% | 289 |
|
|
2018
Q1 | $38.8M | Buy |
962,593
+236,415
| +33% | +$11.5M | 0.07% | 293 |
|
|
2017
Q4 | $38.2M | Sell |
726,178
-121,629
| -14% | -$6.49M | 0.07% | 297 |
|
|
2017
Q3 | $39.9M | Sell |
847,807
-53,242
| -6% | -$2.14M | 0.07% | 269 |
|
|
2017
Q2 | $31.9M | Buy |
901,049
+335,155
| +59% | +$10.3M | 0.06% | 319 |
|
|
2017
Q1 | $13.4M | Buy |
+565,894
| New | +$11.2M | 0.02% | 542 |
|
Other funds holding EXAS
HI
PCM
FCM
DKCM
Macquarie Group's EXAS Position: Q4 2025 in Review
Macquarie Group sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 255,116 shares — an estimated $14M sold.
Macquarie Group first reported a position in EXAS in Q1 2017 and held it in 35 quarters. The position peaked at $300M in Q2 2021. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.
- Macquarie Group reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
- Macquarie Group sold 255,116 Exact Sciences shares in Q4 2025, an estimated $14M.
- Macquarie Group first reported a position in Exact Sciences in Q1 2017 and held it in 35 quarters.
- Macquarie Group's Exact Sciences position peaked at $300M in Q2 2021.
- 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.
Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.